化工社化工社 化学情報印刷レポート · 研究参考用
Imidazole → Climbazole
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Imidazole | HCID 795 | — |
| 反応物 | Water | HCID 962 | — |
| 反応物 | 1-Bromo-1-(4-chlorophenoxy)-3,3-dimethylbutan-2-one | HCID 13269143 | — |
| 反応物 | Imidazoyl ketone | HCID 21924262 | — |
| 溶媒 | Acetonitrile | HCID 6342 | — |
| 生成物 | Climbazole | HCID 37907 | — |
反応手順
The antigingivitis agent utilized in present invention is 1-imidazoyl-(p-chlorophenoxy)3-3-dimethyl 2-butanone having the structural formula: ##STR2## which is prepared by reacting 1-bromo-1-(4-chlorophenoxy)-3,3-dimethyl-2-butanone with imidazole dissolved in acetonitrile as disclosed in U.S. Pat. Nos. 3,812,142 and 3,903,287, which is made a part of this specification. This imidazoyl ketone is a water insoluble crystalline powder having a melting point of 94.5°-97.8° C. which may be obtained from the Bayer Company as Climbazole. Due to the water insolubility of this imidazole compound, it must first be solubilized in a nonionic compound prior to the addition of ionic materials in an aqueous medium.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US04514382 |
| 出典データセット | uspto-grants-1985_04 |
| ORD ID | ord-0c06c30f47d243f7943f6a72356ccafd |
| 出典メモ | uspto-grants-1985_04 |